The market performance of FibroGen Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $20.90 on 04/18/23, while the lowest value for the same duration was $0.33 on 11/10/23.
52-week price history of FGEN Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. FibroGen Inc’s current trading price is -89.67% away from its 52-week high, while its distance from the 52-week low is 548.06%. The stock’s price range during the 52-week period has remained between $0.33 and $20.90. In the Healthcare sector, the company’s shares saw a trading volume of around 0.89 million for the day, which was evidently lower than the average daily volume of 2.61 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
FibroGen Inc (FGEN) has experienced a quarterly rise of 143.71% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 213.34M and boasts a workforce of 486 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.31, with a change in price of +1.60. Similarly, FibroGen Inc recorded 2,393,095 in trading volume during the last 100 days, posting a change of +286.27%.
FGEN Stock Stochastic Average
FibroGen Inc’s raw stochastic average for the past 50 days is presently 64.27%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 42.34%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 54.16% and 60.25%, respectively.
FGEN Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 143.71%. However, over the past six months, we’ve seen a weaker performance of 150.32%. The price of FGEN fallen by 18.03% over the last 30 days. And in the last five days, it has fallen by -18.18%.
